ORCID Workshop for Researchers

TODAY, 1 - 2 PM

Zoom Webinar - Register here

Getting and using your free ORCID iD and ORCID record can help you save time and get credit for your work in funding, publishing, and research reporting workflows. Funding organizations, publishers, and research institutions are increasingly requiring or asking for ORCID iDs from researchers, so this workshop will help you make sure you are ahead of the game. This webinar is free and open to anyone who is interested. The session will be recorded and shared with all who register.

More Information

Tulane Innovation Institute's Startup Nola Now Happy Hour

TODAY - 5:00 - 7:00 PM

The Broadside

600 N. Broad St., New Orleans 70119

Whether you’re a founder, investor, or community member— stop by and make valuable connections within the New Orleans startup ecosystem. This event will include free food, drinks, live music, prizes, and more!

RSVP TO ATTEND HERE

Tulane University Human Research Protection Office

Educational Opportunities for Researchers

Wednesday, May 8

Morning Session - 9:30 AM - 11:30 AM

Afternoon Session - 1:00 PM - 3:00 PM

Tidewater Building

1440 Canal St., New Orleans, Room 1708

Attend in person or via Zoom

The Human Research Protection Office (HRPO) is excited to collaborate with the renowned Institutional Review Board (IRB) experts from the HRP Consulting Group to offer comprehensive, in-person training sessions exclusively designed for researchers.

This training is specifically designed around the questions that researchers have submitted in advance. It’s a unique opportunity to stay updated with the latest developments in the human subjects research field. One-on-one sessions are also offered for personalized guidance.

Researchers are encouraged to attend in person when possible.

Please click this link to register. Once you have selected the session you wish to attend, an invitation will be sent to you.

LSU / LCMC Health Cancer Center Faculty Candidate Seminar

Store-Operated Calcium Entry Channels in Metabolism and Disease

Trayambak Pathak, PhD

Postdoctoral Fellow

Department of Pharmacology and Chemical Biology

Vascular Medicine Institute, University of Pittsburgh

Wednesday, May 8 - Noon - 1:00 PM

Louisiana Cancer Research Center - 1st Floor Conference Room

Lunch Available at 11:45 AM

Zoom Meeting ID: 928 8909 2861

Passcode: 678182

REGISTRATION DEADLINE:

MAY 9 - 11:00 AM CST

ARPA-H Biohybrid Therapeutic Devices Summit

Thursday, May 16 - 8:30 AM - 6:30 PM

Friday, May 17 - 8:30 AM - 5:30 PM

Le Meridien Hotel New Orleans

333 Poydras St.

ARPA-H has invested in several implantable devices that merge advances in synthetic biology, bioelectronics, and materials science to create "Living Pharmacies" that continuously deliver a range of therapies for cancer, diabetes or obesity under bioelectronic control (THOR, REACT, REO). ARPA-H is dedicated to translation of technologies, constantly searching for any bottlenecks or roadblocks that might be ameliorated with early investment. The Biohybrid Therapeutic Devices Summit is being organized to bring together key funders, stakeholders, scientists, regulatory authorities, patient engagement groups, and the private sector to advance the field.

Topics to be addressed include unmet needs, manufacture, regulatory strategies, ELSI, and commercialization requirements of the field. The format includes presentations, poster session and breakout sessions on Cancer, Diabetes, Ethics & User Interface.

Register here: https://solutions.arpa-h.gov/BIOHYBRID/

Louisiana Cancer Research Center Seminar Series

The Role of Cancer Cells with Both Epithelial and Mesenchymal Traits in Metastasis and Approaches to Target These Cells

Sendurai Mani, PhD

Dean's Chair of Translational Oncology

Associate Director of Translational Oncology

Professor of Pathology and Laboratory Medicine

Brown University -

Legoretta Cancer Center

Thursday, May 9 - Noon - 1 PM

Louisiana Cancer Research Center - 1st Floor Conference Room

Lunch will be available at 11:45 AM

Zoom Meeting ID: 988 3427 6980

Passcode: 050968

American Association for Cancer Research Invites Applicants for Victoria's Secret Global Fund for Women's Cancers

APPLICATION DEADLINE: MAY 15, 2024 - NOON CST

The American Association for Cancer Research invites applications for the Victoria’s Secret Global Fund for Women’s Cancers. In partnership with Pelotonia, the fund aims to support innovative research projects in breast and gynecologic cancers and to invest in the next generation of female early-stage scientists domestically and globally.

Through the fund, grants of $206,000 over two years will be awarded in support of basic, translational, clinical, or population sciences research. Proposals focused on research into the causes of cancer health disparities and approaches to achieve equity in outcomes, as well as applicants belonging to racial or ethnic groups shown to be underrepresented in the cancer-related sciences workforce are especially encouraged.

To be eligible, applicants must be female investigators with a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree.

For complete program guidelines and application instructions, see the American Association for Cancer Research website.

Tulane University School of Medicine Center for Immunity & Musculoskeletal Diseases Research Seminar

Discovering Skeletal Stem and Progenitor Cells In Vivo

Dr. Ling Qin

Professor

Department of Orthopedic Surgery University of Pennsylvania

School of Medicine

Wednesday, May 15 - Noon - 1:00 PM

Zoom Link: https://tulanehipaa.zoom.us/j/99562648593

Promising Practices Conference on Community Health

Friday, May 24

Grambling State University Online and Onsite

Presented by the Louisiana Cancer Research Center Office of Community Outreach and Engagement, this program is designed to support communities in improving health and wellness and reducing cancer in Louisiana. Community and health advocates from across the state are expected to attend.

REGISTER HERE

NRSA Postdoctoral Research Fellowship

Deep South KUH Premier Research - Interdisciplinary Mentored Education (PRIME) Training

NIH-NRSA Training Grant - TL1 DK139566

Application Deadline: June 1, 5:00 PM

Applications Reviewed as Received

NIH-funded training grant post-doctoral fellowships are available for research training in the areas broadly related to Kidney, Urology, and non-malignant Hematology diseases. Trainees will pursue a one to two-year research program in the laboratory of an established basic or clinical research mentor, supplemented with training in advanced biostatistics and bioethics courses.

Trainees will be required to carry out an independent research project in the laboratory of a faculty mentor - a basic scientist or clinician investigator experienced in kidney, urology and non-malignant hematology disease-related research at Augusta University (AU), Tulane University (TU) or The University of Alabama at Birmingham (UAB). Current areas of research interest include renal transport physiology, acute and chronic kidney disease, diabetic kidney disease, cell and developmental biology pertaining to the kidney, polycystic kidney disease, hypertension, glomerular diseases, dialysis-related vascular access, lower urinary tract disease, inflammation and immunology, red cell pathology, nephrolithiasis, genetic diseases, sickle-cell disease, basic and clinical research in transplantation and outcomes/epidemiology research.

Selection of trainees is based on the demonstrated ability of the candidate and trainee’s career plan and potential for an academic career. Applicants must be United States citizens or permanent residents and have completed their MD or PhD by the start date of the fellowship.

More Information

CDMRP / FY24 Rare Cancers Research Program

SYNOPSIS OF FY24 RCRP AWARD MECHANISMS

CDMRP / FY24 Breast Cancer Research Program

SYNOPSIS OF FY24 BCRP AWARD MECHANISMS

CDMRP / FY24 Lung Cancer Research Program

SYNOPSIS OF FY24 LCRP AWARD MECHANISMS

CDMRP / FY24 Ovarian Cancer Research Program

SYNOPSIS OF FY24 OCRP AWARD MECHANISMS

CDMRP / FY24 Peer-Reviewed Medical Research Program

SYNOPSIS OF FY24 PRMRP AWARD MECHANISMS

NIAID Notice of Special Interest: Inborn Errors of Immunity / Primary Immunodeficiencies (R03, R21, R01 mechanisms)

NOT-AI-24-024

This notice applies to due dates on or after June 5, 2024, and subsequent receipt dates through March 16, 2027.

The purpose of this Notice of Special Interest (NOSI) is to support research on the discovery and characterization of Inborn Errors of Immunity (IEIs), also referred to as Primary Immunodeficiencies, to understand the causes and mechanisms of disease, enable early detection and molecular diagnosis, and support the development of strategies to treat and eventually cure these disorders.

More Information

NIH: New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)

PAR-24-160

STANDARD DUE DATES: 6/5, 10/5, 2/5

Funds Available and Anticipated Number of Awards: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Award Budget:  Application budgets are not limited but need to reflect the actual needs of the proposed project.

The brain is a highly dynamic and consequential organ that undergoes dramatic shifts in cellular composition, connectivity, and activity patterns across the lifespan. A key factor limiting our understanding of these changes, particularly over longer time periods, is the paucity of methods to study longer-term trajectories. Better approaches are needed to link nervous system structure and function, as well as genetic and environmental influences, across time periods and levels of temporal and spatial resolution. This notice of funding opportunity encourages multidisciplinary collaborations to develop novel approaches or improve existing ones for longitudinal or cross-sectional brain measures across the lifespan. The ultimate goal of this funding opportunity is to improve our understanding of how each stage in brain development, starting from prenatal origins, leads to the next one, and how the parameters that are set at each stage predict later brain health or disease.  

More Information

NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional)

PAR-24-153

APPLICATION DUE DATE: JUNE 18, 2024

The purpose of the NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12) is to support the training of clinical scientists in community cancer prevention, screening, intervention, control, and treatment research. Special emphasis is placed on training clinical scientists whose career goal is to improve the care and outcomes of minority health populations and populations with health disparities that are underrepresented in clinical research by increasing their access to and representation as human subjects in cancer clinical trials using an equity lens.

This Notice of Funding Opportunity (NOFO) allows the appointment of Scholars proposing to serve as the lead investigator of an independent community-based clinical trial; proposing to increase the integration of cancer health disparities research questions into clinical trials; or proposing a separate ancillary study to an existing prevention, screening, intervention, control or treatment trial; or proposing to gain research experience in a community-based clinical trial led by another investigator; or proposing to serve as leader of innovative clinical trial approaches that expand engagement of minority health populations and populations with health disparities that are underrepresented as human subjects in cancer clinical trials, as part of their research and career development. 

NCI Cancer Control and Population Sciences

New Notice of Special Interest

The Epidemiology and Genomics Research Program in NCI's Division of Cancer Control and Population Sciences is sharing information about a new Notice of Special Interest, listed below. The NIH Guide for Grants and Contracts notices provide more details and contact information for inquiries.

NOT-CA-24-031: Validation of Digital Health and Artificial Intelligence/Machine Learning Tools for Improved Assessment in Biomedical and Behavioral Research 

EXPIRATION DATE: JULY 6, 2025

Profiling the activity of the para-caspase MALT1 in B-cell acute lymphoblastic leukemia for potential targeted therapeutic application. Safa FM, Rasmussen T, Fontan L, Xia M, Melnick A, Wiestner A, Lobelle-Rich P, Burger JA, Mouawad Y, Safah H, Flemington EK, Saba NS. Haematologica. 2024 May 1;109(5):1348-1358. doi: 10.3324/haematol.2023.283178. PMID: 37767562

Patient-Caregiver Dyads & End-of-Life Care: Caregiver Personality Disrupts Gender-Based Norms. Mossman B, Perry LM, Voss HM, Maciejewski PK, Gramling R, Duberstein P, Prigerson HG, Epstein RM, Hoerger M. J Pain Symptom Manage. 2024 May;67(5):e393-e398. doi: 10.1016/j.jpainsymman.2024.01.030. Epub 2024 Jan 24. PMID: 38278189

Next Generation Sequence Analysis Core

The Tulane Cancer Center NGS Analysis Core team assists investigators with furthering their research through comprehensive processing and analysis of data obtained from widely used high-throughput sequencing applications.

More Information 

Cell Analysis Core

The Cell Analysis Core Facility is designed to collaborate with investigators and contribute to all aspects of the research process, including consultation in experimental design, data analysis and storage, troubleshooting, interpretation of results, and the preparation and production of presentation graphics.

More Information

Tulane Cancer Center Membership

Please click here for Tulane Cancer Center's membership guidelines and our online application form.

Tulane Cancer Center's Website & Facebook Page

Subscribe to Nexus

If you know someone who is interested in subsribing to Nexus, a weekly round-up of news and information for Tulane cancer researchers, please have them contact Melanie Cross at mcross@tulane.edu.

Please share your feedback. Is this newsletter helpful? What other information should we include? And send us your news and announcements regarding seminars, workshops, funding opportunities, new grants, recent publications or events by emailing Melanie Cross at mcross@tulane.edu.